Model 4063 Inspire Stimulation Lead
Inspire Medical Systems · Decision date Aug 11, 2026
What did the FDA decide?
FDA records P130008/S142 as a supplement to PMA P130008, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 11, 2026.
FDA approval order statement
updates to Model 4063 Inspire Stimulation Lead Manufacturing Final Pack and Sterile Packaging work instructions
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Anesthesiology
- Decision date
- Aug 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P130008/S142
- Regulatory pathway
- PMA supplement
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- Decision code
- OK30
- Decision date
- Aug 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.
FDA decision timeline
P130008 · Original PMA
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S127 · Related supplement
MODEL 3150 IMPLANTABLE PULSE GENERATOR (IPG)
P130008/S129 · Related supplement
Model 2740 Inspire Programmer; Model 2740S/C SleepSync Programming System
P130008/S131 · Related supplement
Inspire Upper Airway Stimulation
P130008/S130 · Related supplement
Inspire Upper Airway Stimulation
P130008/S132 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S133 · Related supplement
QMR Battery Separator Supplier
P130008/S124 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S135 · Related supplement
Model 3028 Connector Block Laser Weld Inspection Update
P130008/S137 · Related supplement
Model 3150 Implantable Pulse Generator (IPG)
P130008/S138 · Related supplement
Inspire V Printed Circuit Board Assembly (PCBA) Test System SW
P130008/S139 · Related supplement
Inspire Model 4063 Leads; Inspire Model 4340 Leads
P130008/S140 · Related supplement
Model 3150 Implantable Pulse Generator (IPG)
P130008/S142 received
Application receipt date recorded by FDA.
P130008/S142 · FDA decision
30-Day Notice
P130008/S143 · Related supplement
Inspire Upper Airway Stimulation (UAS) System
P130008/S123 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S136 · Related supplement
Model 4063 Inspire Stimulation Lead
P130008/S146 · Related supplement
Model 3150 IPG
P130008/S147 · Related supplement
Model 3150 IPG
P130008/S144 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 · Related supplement
Model 4063 Dedicated Tray Sealer
Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130008
Explore the linked device profile
Other records with product code MNQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Genio System 2.1P240024/S004 | Nyxoah S.A. | PMA supplement | Jul 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inspire Medical Systems
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369
Sources and methodology
- Original FDA record: P130008/S142
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






